Warning over direct-to-consumer genetic tests

GPs can expect increasing numbers of inquiries from patients wanting advice after ordering direct-to-consumer genetic tests, Australian experts say.

Overseas companies, such as 23andMe, are pushing ahead with promotion of direct-to-consumer genetic tests that claim to provide genetic risk information for 10 conditions, including Parkinson's disease and late-onset Alzheimer's disease, says public health physician adjunct Associate Professor Ken Harvey.

Writing in Australian Prescriber, Dr Harvey is urging GPs to advise their patients against purchasing these expensive, unnecessary